Abstract
Introduction Humanitarian emergencies, of either natural or anthropogenic origins, are equivalent to major disasters, which can lead to population displacement, food insecurity and health system disruptions. Almost two-thirds of persons affected by humanitarian emergencies inhabit malaria endemic regions, particularly the World Health Organization (WHO) African Region, which currently accounts for 93% and 94% of malaria cases and deaths, respectively. As of late 2020, the United Nations Refugee Agency estimates there are globally 79.5 million forcibly displaced people, including 45.7 million internally displaced people, 26 million refugees, 4.2 million asylum-seekers and 3.6 million Venezuelans displaced abroad.
Methods and analyses A systematic review and meta-analysis will be conducted to evaluate the impact of different vector control interventions on malaria disease burden during humanitarian emergencies. Published and grey literature will be systematically retrieved from ten electronic databases and three clinical trials registries. A systematic approach to screening, reviewing and data extraction will be applied based on the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. Two review authors will independently assess full-text copies of potentially relevant articles based on inclusion criteria. Included studies will be assessed for risk of bias according to Cochrane and certainty of evidence using the GRADE approach. Eligible studies with reported or measurable risk ratios or odds ratios with 95% confidence intervals will be included in a meta-analysis. Sub-group analyses, including per study design, emergency phase, and primary mode of intervention, may be performed if substantial heterogeneity is encountered.
Ethics and dissemination Ethical approval is not required by the London School of Hygiene and Tropical Medicine to perform secondary analyses of existing anonymous data. Study findings will be disseminated via open-access publications in peer-reviewed journals, presentations to stakeholders and international policy makers, and will contribute to the latest WHO guidelines for malaria control during humanitarian emergencies.
PROSPERO registration number CRD42020214961.
Strengths and limitations of this study
⇒ This will be the first systematic review and meta-analysis of the impact of different vector control interventions on malaria disease burden during humanitarian emergencies, providing a comprehensive global evidence summary that can be updated as new evidence emerges.
⇒ Inclusion of a broad range of study types will allow the identification of studies from a diverse range of humanitarian contexts.
⇒ By definition, humanitarian emergencies are unpredictable and volatile and consequently these settings can be restrictive with respect to study design, limiting the number of community-level randomised control trials with epidemiological outcomes which can be considered in this review.
⇒ Lack of a sensitive literature search strategy may result in a large number of titles and abstracts to screen initially.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
PROSPERO registration number CRD42020214961
Funding Statement
This work was supported by the World Health Organization Global Malaria Programme (WHO-GMP). LAM, JFA and MR are supported by the DFID/MRC/NIHR/Wellcome Trust Joint Global Health Trials Scheme. LAM and MR are also supported by UNITAID/Global Fund and DFID-RPC. BP is supported by the LSHTM-Nagasaki University Joint PhD Programme for Global Health.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval is not required by the London School of Hygiene and Tropical Medicine to perform secondary analyses of existing anonymous data.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data are freely available from the corresponding author upon reasonable request.
